MaxCyte
MXCT • NASDAQ
MaxCyte is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Maher Masoud, with a market cap of $73.1M.
CEOMaher Masoud
Next Earnings
Upcoming earnings announcement for MaxCyte
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.09
Revenue Estimate
$7.4M
Earnings History
Past 12 earnings reports for MaxCyte
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Q4 2025 | -$0.09Est: -$0.08 | -12.5% | $7.3MEst: $9.2M | -20.3% | — |
| Nov 12, 2025 | Q3 2025 | -$0.12Est: -$0.10 | -20.0% | $6.8MEst: $8.9M | -23.4% |  10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.12Est: -$0.10 | -20.0% | $8.5MEst: $9.7M | -12.4% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.10Est: -$0.10 | 0.0% | $10.4MEst: $9.1M | +14.8% | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$0.10Est: -$0.12 | +16.7% | $8.7MEst: $7.9M | +9.9% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.11Est: -$0.12 | +8.3% | $8.2MEst: $7.4M | +10.8% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.09Est: -$0.13 | +30.8% | $10.4MEst: $7.9M | +31.7% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.09Est: -$0.13 | +30.8% | $11.3MEst: $7.5M | +52.0% | 10-Q |
| Mar 12, 2024 | Q4 2023 | -$0.05Est: -$0.07 | +28.6% | $15.7MEst: $13.1M | +19.7% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.11Est: -$0.10 | -10.0% | $8.0MEst: $9.8M | -18.1% | — |
| Aug 9, 2023 | Q2 2023 | -$0.10Est: -$0.10 | 0.0% | $9.0MEst: $10.8M | -16.3% | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.11Est: -$0.11 | 0.0% | $8.6MEst: $8.3M | +3.1% | 10-Q |